Compass Therapeutics, Inc.: Form SC 13D/A, filed Mar 22, 2024
Filed with the SEC on Mar 22, 2024 and accepted by EDGAR at Mar 22, 2024, 20:59 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000947871-24-000303. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.